F17.298
Nicotine dependence, other tobacco product, with other nicotine-induced disorders
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F17.298 refers to a condition where an individual is dependent on tobacco products other than cigarettes, such as cigars, smokeless tobacco, or e-cigarettes. This dependence is accompanied by additional health issues caused by nicotine, which can affect various parts of the body. Recognizing this condition is important for addressing addiction and related health concerns, although specific treatment plans should be discussed with healthcare providers.
Causes & Symptoms
Clinical Causes: Repeated use of non-cigarette tobacco products, like smokeless tobacco, cigars, or e-cigarettes. Genetic predisposition toward nicotine addiction. Environmental factors, including peer pressure and advertising influences. Psychological factors such as stress or mental health conditions that increase the likelihood of tobacco use. Habit formation over time resulting from regular exposure to nicotine.
Key Symptoms: Persistent craving for tobacco products. Difficulty controlling or reducing tobacco use despite wanting to stop. Experiencing withdrawal symptoms such as irritability, anxiety, or difficulty concentrating when not using tobacco. Tolerance, needing more tobacco over time to achieve the same effects. Physical signs of nicotine dependence like increased heart rate or elevated blood pressure. Use of tobacco in hazardous situations, such as during work or before driving.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves clinical evaluation of tobacco use history and signs of dependence. Healthcare professionals may use questionnaires or screening tools to assess the level of dependence and the presence of nicotine-induced disorders. Laboratory tests are generally not used for diagnosing dependence but may be used to measure nicotine levels in research settings or for supporting evidence of related health effects.
Treatment Protocols: Treatment often includes behavioral counseling and support programs tailored to help individuals quit tobacco products. Pharmacological options such as nicotine replacement therapy (patches, gum, lozenges), medications like varenicline or bupropion, may be recommended to reduce withdrawal symptoms and cravings. Combining counseling with medication increases the chances of successful cessation. Ongoing support and follow-up are essential components to prevent relapse.
Clinical Advice & FAQs
Billing Guidance
Is F17.298 a billable ICD-10 code?
Yes, F17.298 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F17.298?
Clinical documentation must specify the nature of Nicotine dependence, other tobacco product, with other nicotine-induced disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
